Showing results (1791-1800 of 1,996) with videos related to

Sort By:
Pageof 200
The Lancet. Neurology|June 15, 2007
Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort studyGili Kenet, Fenella Kirkham, Thomas Niederstadt, et al.
The Lancet. Neurology|July 6, 2007
Epilepsy and risk of suicide: a population-based case-control studyJakob Christensen, Mogens Vestergaard, Preben Bo Mortensen, et al.
The Lancet. Neurology|July 18, 2009
Motor recovery after stroke: a systematic reviewPeter Langhorne, Fiona Coupar, Alex Pollock
The Lancet. Neurology|October 6, 2009
Imaging biomarkers of outcome in the developing preterm brainLaura R Ment, Deborah Hirtz, Petra S Hüppi
The Lancet. Neurology|October 6, 2009
Prevention and management of stroke in very elderly patientsNerses Sanossian, Bruce Ovbiagele
The Lancet. Neurology|October 6, 2009
Epilepsy in later lifeMartin J Brodie, Andrew T Elder, Patrick Kwan
The Lancet. Neurology|August 24, 2010
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trialMurat Emre, Magda Tsolaki, Ubaldo Bonuccelli, et al.
The Lancet. Neurology|May 4, 2010
Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trialAdrian Williams, Steven Gill, Thelekat Varma, et al.
The Lancet. Neurology|August 9, 2011
FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic studyAnu Suomalainen, Jenni M Elo, Kirsi H Pietiläinen, et al.
The Lancet. Neurology|September 10, 2011
Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trialElizabeth Leroux, Dominique Valade, Irina Taifas, et al.
Pageof 200